| Financial Year |
March 31 2023 |
| Monetary Funds |
276,917,982.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,382,534.60 |
| Accounts Receivable |
241,971,010.57 |
| Advances to Suppliers |
33,946,757.07 |
| Other Receivables |
4,193,187.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
112,888,144.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
421,409.65 |
| Total Current Assets |
673,721,026.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
111,376,128.92 |
| Fixed Assetes |
322,516,609.72 |
| Under-construction Projects |
12,414,156.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,774,669.50 |
| R&D expenses |
-- |
| Goodwill |
13,724,166.60 |
| Long-Term Deferred and Prepaid Expenses |
126,350.17 |
| Deferred Income Tax Assets |
8,580,062.94 |
| Other Non-Current Assets |
14,047,631.33 |
| Sub-Total of Non-Current Assets |
598,759,775.75 |
| Total Assets |
1,272,480,801.75 |
| Short-Term Loans |
30,033,458.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
282,858,760.01 |
| Accounts Received In Advance |
149,464.23 |
| Employee Compensation Payable |
3,823,851.97 |
| Taxes Payable |
20,736,409.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
113,928,322.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,118,866.76 |
| Sub-Total of Current Liabilities |
480,265,552.11 |
| Long-term Loans |
112,287,533.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
139,278,834.59 |
| Total Liabilities |
619,544,386.70 |
| Paid-In Capital(Or Share Stock) |
303,345,000.00 |
| Capital Surplus |
55,755,877.41 |
| Surplus Reserve |
29,497,119.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
201,353,815.07 |
| Minority Stockholder's Interest |
62,984,603.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
589,951,811.93 |
| Owner's Equity（Stockholder's Equity） |
652,936,415.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,272,480,801.75 |
